Skip to main content

Table 2 Library of immunogenic peptide epitopes used to evaluate CD8+ T cell responses to breast-cancer-associated antigens

From: A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies

Mammaglobin-A

LIY83-92

LIYDSSLCDL

34

Trag-3

HAC 37-45

HACWPAFTV

35

 

SIL 57-66

SILLRDAGLV

35

Survivin

ELT 95-104

ELTLGEFLKL

36

 

LDR 104-113

LDRERAKNKI

36

Mucin-1

LLL 12-20

LLLLTVLTV

33

 

STA 950-958

STAPPVHNV

33

Bcl-xL

RIA 165-174

RIAAWMATYL

13

 

YLN 173-182

YLNDHLEPWI

13

Her2/neu

KIF 369-377

KIFGSLAFL

12

 

CLT 789-797

CLTSTVQLV

12

 

VLV 851-859

VLVKSPNHV

12

 

ELV 971-979

ELVSEFSRM

12

  1. HER-2, human epidermal growth factor receptor-2; Trag-3, taxol-resistance associated gene 3.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us